Skip to content
Search

Latest Stories

Shooting of John Abraham and Divya Khosla Kumar starrer Satyameva Jayate 2 to start tomorrow

Murtuza Iqbal

Director Milap Zaveri and actor John Abraham are all set to team up for the second time for the sequel to 2018 release Satyameva Jayate. Titled Satyameva Jayate 2, the movie will mark the big-screen comeback of actress Divya Khosla Kumar.


The movie was supposed to start rolling earlier this year and was slated to hit the big screens on 2nd Oct 2020. However, due to the pandemic, the shooting was postponed and now, the film is all set to go on the floors tomorrow in Lucknow.

While talking to Mumbai Mirror, director Milap Zaveri stated, “On the first day, we will shoot only with the lead pair, but subsequently, other actors like Harsh Chhaya, Gautami Kapoor, Shaad Randhawa, Anup Soni, and Sahil Vaid will join in. We will be shooting across Lucknow, including at heritage structures like palaces and colleges. Some of the live locations will be completely sealed off, so crowd gazers cannot sneak in. Only our cast and crew will be present on the spot.”

Shooting in the pandemic that too on the real locations won’t be easy for the team, however, producer Bhushan Kumar is confident that with strict SoPs it will be a safe shooting environment.

The producer told the tabloid, “It will be scary for the crew at live locations, but it is important to give our audience some entertainment during this pandemic. When we decide to take a franchise forward, we have to be ready with larger-than-life stories and characters. This script is a notch higher and Milap has worked rigorously on the action scenes with John during the lockdown.”

Satyameva Jayate 2 is co-produced by Nikkhil Advani under his banner Emmay Entertainment. The movie is slated to release on Eid next year and director Milap Zaveri feels that his film is perfect for the festival release.

He said, “It’s a franchise that celebrates the victory of good over evil and that’s a perfect recipe for Eid. Plus, there’s lots of action, drama, and dialoguebaazi.”

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less